Can a common medical practice transform Candida infections from benign to deadly?
Stephenson
J
J
D000925:Anticoagulants / Q000494:pharmacology; D002176:Candida albicans / Q000472:pathogenicity*; D002177:Candidiasis / Q000276:immunology*; D002404:Catheterization; D015815:Cell Adhesion Molecules; D005656:Fungal Proteins; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D009183:Mycotoxins; D009894:Opportunistic Infections / Q000276:immunology*; D018089:Superantigens; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology
D000925:Anticoagulants; D015815:Cell Adhesion Molecules; D005656:Fungal Proteins; D009183:Mycotoxins; D018089:Superantigens; C097687:alphaINT1 protein, Candida albicans; D006493:Heparin